Biogen Idec, Inc. (BIIB) Reports Solid Q2 Results

Article Stock Quotes (1) Comments (0)

Biogen Idec, Inc. (NASDAQ: BIIB) reported Q2 EPS of $1.82, $0.26 better than the analyst estimate of $1.56. Revenue for the quarter came in at $1.4 billion versus the consensus estimate of $1.33 billion.

For earnings history and earnings-related data on Biogen Idec, Inc. (BIIB) click here.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• Five Below (FIVE) Tops Q1 EPS by 1c, Boosts FY13 Outlook
• Lentuo International (LAS) Swings to Q1 Loss; Updates on Expansion
• Capstone Turbine Corp (CPST) Reports In-Line Q4 EPS of 1c/Share

Create E-mail Alert Related Categories

Earnings

Related Entities

Earnings

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?